Komori
Ajinomoto Co. (2802) · RiskRestated

Demand, Operational and Financial Risks Arising from COVID-19

First written in FY2020. 7 of 14 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2025-H1.

14entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2021-Q1 – FY2022-Q3OtherFY2022 – FY2025-H12020: 320202021: 420212022: 420222023: 220232024: 12024
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1250 companies write about · 1262 as a headwind · 6 as a tailwind

Ajinomoto Co. moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

49 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1276 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes concerning demand, operational or financial risks from COVID-19.
  2. FY2024-Q2RestatedAnnual report

    「No new business or other risks arose during the cumulative second-quarter period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes concerning demand, operational or financial risks from COVID-19.
  3. FY2024-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the first quarter of the current consolidated cumulative period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes concerning demand, operational or financial risks from COVID-19.
  4. FY2023-Q2Continuing Impact on Accounting EstimatesAnnual report

    「The economic normalisation following the COVID-19 pandemic and changes in the international situation surrounding Ukraine have caused impacts including an acceleration in increases in global raw material and fuel prices. However, as it is difficult to predict how the spread of COVID-19 and the situation in Ukraine will develop, we are considering, based on external information and analyses of market trends in each country, whether there are indications that non-financial assets may be impaired and other matters, assuming that these impacts will continue for a certain period in the future.」

    The company is considering, for accounting purposes, indicators of impairment of non-financial assets and other matters, assuming that the impact of rising raw material and fuel prices associated with economic normalisation following the COVID-19 pandemic and the situation in Ukraine will continue.
  5. FY2023-Q1Demand Recovery and Continuing ImpactAnnual report

    「For the current first quarter of the fiscal year, revenue was ¥276.3 billion, up ¥28.4 billion year on year, or 111.5% of the prior-year period. This reflected strong sales of consumer products, mainly overseas, in the seasonings and foods and frozen foods businesses, a partial recovery in sales of products for restaurants and commercial customers that had been affected by the spread of COVID-19 in the prior fiscal year, and substantial revenue growth in healthcare and other businesses.」

    Sales of products for restaurants and commercial customers affected by the spread of COVID-19 showed a partial recovery, while strong overseas sales of consumer products also contributed to higher revenue. At the same time, the impact of the pandemic continued to be cited as a factor in comparisons with the prior-year period.
  6. FY2022Full-Year Results Update and Demand RecoveryAnnual report

    「For the fiscal year, revenue was ¥1,071.4 billion, down ¥28.5 billion year on year, or 97.4% of the prior fiscal year. Amid the global spread of COVID-19, sales of consumer products, mainly in the seasonings and foods and frozen foods businesses, increased on stronger demand for at-home consumption, while sales of products for restaurants and commercial customers continued to decline due to lockdowns and other factors, despite signs of recovering demand from restaurants.」

    The impact of COVID-19 remained evident for the full year in increased demand for at-home consumption and decreased demand from restaurants and commercial customers, although signs of recovery were also seen in demand from restaurants.
  7. FY2022-Q3MaterialisedAnnual report

    「For the first nine months of the current fiscal year, revenue was ¥854.2 billion, up ¥59.2 billion year on year, or 107.5% of the prior-year period. This reflected strong sales of consumer products, mainly overseas, and a partial recovery in sales of products for restaurants and commercial customers that had been affected by the spread of COVID-19 in the prior fiscal year, as well as substantial revenue growth in the healthcare and other segment, mainly due to strong sales of electronic materials and biopharmaceutical services.」

    While sales of products for restaurants and commercial customers affected by COVID-19 showed a partial recovery, changes in demand resulting from the spread of infection in the prior year continued to be a factor in comparing sales for the first nine months of the current fiscal year.
  8. FY2022-Q2MaterialisedAnnual report

    「For the first six months of the current fiscal year, revenue was ¥550.2 billion, up ¥38.8 billion year on year, or 107.6% of the prior-year period. This reflected strong sales of consumer products, mainly overseas, and a partial recovery in sales of products for restaurants and commercial customers that had been affected by the spread of COVID-19 in the prior fiscal year, as well as substantial revenue growth in the healthcare and other segment, mainly due to strong sales of electronic materials and biopharmaceutical services.」

    Sales of products for restaurants and commercial customers affected by COVID-19 showed a partial recovery, while strong overseas sales of consumer products and other factors also contributed, bringing revenue to 107.6% of the prior-year period.
  9. FY2022-Q1MaterialisedAnnual report

    「For the current first quarter of the fiscal year, revenue was ¥276.3 billion, up ¥28.4 billion year on year, or 111.5% of the prior-year period. This reflected strong sales of consumer products, mainly overseas, in the seasonings and foods and frozen foods businesses, a partial recovery in sales of products for restaurants and commercial customers that had been affected by the spread of COVID-19 in the prior fiscal year, and substantial revenue growth in healthcare and other businesses.」

    Sales of products for restaurants and commercial customers affected by COVID-19 showed a partial recovery, while strong overseas sales of consumer products also contributed, bringing current first-quarter revenue to 111.5% of the prior-year period.
  10. FY2021MaterialisedAnnual report

    「For the fiscal year, revenue was ¥1,071.4 billion, down ¥28.5 billion year on year, or 97.4% of the prior fiscal year. Amid the global spread of COVID-19, sales of consumer products, mainly in the seasonings and foods and frozen foods businesses, increased on stronger demand for at-home consumption, while sales of products for restaurants and commercial customers continued to decline due to lockdowns and other factors, despite signs of recovering demand from restaurants.」

    The impact of the pandemic remained evident for the full year in the combination of increased sales of consumer products and decreased sales of products for restaurants and commercial customers, with revenue at 97.4% of the prior fiscal year.
  11. FY2021-Q3MaterialisedAnnual report

    「For the first nine months of the current fiscal year, revenue was ¥794.9 billion, down ¥27.4 billion year on year, or 96.7% of the prior-year period. Amid the global spread of COVID-19, sales of consumer products, mainly in the seasonings and foods and frozen foods businesses, increased on stronger demand for at-home consumption, while sales of products for restaurants and commercial customers continued to decline due to lockdowns and other factors, despite signs of recovering demand from restaurants.」

    The spread of COVID-19 resulted in both increased sales of consumer products for at-home consumption and decreased sales of products for restaurants and commercial customers, with revenue reaching 96.7% of the prior-year period.
  12. FY2021-Q2MaterialisedAnnual report

    「For the first six months of the current fiscal year, revenue was ¥511.3 billion, down ¥20.8 billion year on year, or 96.1% of the prior-year period. Amid the global spread of COVID-19, sales of consumer products, mainly in the seasonings and foods and frozen foods businesses, increased on stronger demand for at-home consumption, while sales of products for restaurants continued to decline despite signs of recovering demand.」

    The spread of COVID-19 resulted in both increased sales of consumer products driven by demand for at-home consumption and decreased sales of products for restaurants, with revenue reaching 96.1% of the prior-year period.
  13. FY2021-Q1MaterialisedAnnual report

    「For the current first quarter of the fiscal year, revenue was ¥247.9 billion, down ¥15.8 billion year on year, or 94.0% of the prior-year period. Amid the global spread of COVID-19, sales of consumer products, mainly in the seasonings and foods and frozen foods businesses, increased on stronger stay-at-home demand, while sales of products for restaurants and commercial customers declined due to lockdowns and other factors.」

    The increase in stay-at-home demand and decline in demand from restaurants and commercial customers amid the spread of COVID-19 became evident in the year-on-year decline in revenue. The impact of the pandemic differed by business, while business profit increased due to higher sales of consumer products and other factors.
  14. FY2020First statedAnnual report

    「In particular, we recognise the COVID-19 pandemic as one of the most significant ongoing business risks. We expect it to take more than one year to move from the current phase of global spread, through a period of coexistence with the virus, to a recovery phase supported by the development of vaccines and other measures. We also expect outbreaks to recur in waves, including second and third waves, in some countries.」

    The company identified COVID-19 independently and explicitly for the first time as a significant ongoing business risk, describing its impact on increased demand for at-home consumption, reduced demand for eating out, the supply chain and liquidity, among other areas.
Moved together

"Foreign Exchange Risk from Increasing Overseas Exposure" moved the same way as this thread, in the same document, in 4 of its 14 moves.

433★123
  1. ★This thread
  2. 1Foreign Exchange Risk from Increasing Overseas Exposure4×
  3. 2Fluctuations in Fuel, Energy and Raw Material Prices and the Risk of Inability to Pass Through Costs3×
  4. 3Higher U.S. logistics costs and increased costs associated with establishing a new production system3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ajinomoto Co. yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Demand, Operational and Financial Risks Arising from COVID-19 | Ajinomoto Co.,Inc. (2802) | Komori